Taiwan-based Bora Pharmaceuticals Co. and Celltrion Asia Pacific, a subsidiary of South Korea-based Celltrion Group Inc,...
Compal Electronics, a Taiwanese electronics company, has announced its expansion into the development of innovative ther...
JelloX Biotech Inc., a Taiwan-based startup focused on cancer pathology, has announced involvement with two new research...
US-based Endonovo Therapeutics, Inc., a medical device company known for its innovative and effective pain management so...
Taiwan's Health2Sync has announced that its latest version of the Health2Sync App integrates insulin data from Mallya Ca...
Taiwan's TaiGen Biotechnology has signed an exclusive licensing agreement with Joincare Pharmaceutical Group, a Chinese ...
AffaMed Technologies, a joint venture established between AffaMed Therapeutics and SIFI S.p.A., have announced that the ...
Taiwan's AnnJi Pharmaceutical Co. has entered into an exclusive license agreement with Amercian firm Avenue Therapeutics...
Kyorin Pharmaceutical, a subsidiary of Kyorin Holdings, Inc. and Sumitomo Pharma, in Japan, have entered into a license ...
Japanese firm Ono Pharmaceutical has received the approval of Opdivo (nivolumab) Intravenous Infusion, a human anti-hu...
Taiwan-based Formosa Pharmaceuticals has entered into a collaboration agreement with US-based Eyenovia, Inc. for the dev...
Taiwan's Lotus Pharmaceutical has announced that together with Adalvo, the company has partnered with Eurofarma, to laun...
INVO Bioscience, a US-based commercial-stage fertility company focused on expanding access to advanced treatment worldwi...
Taiwan Ministry of Economic Affairs has commissioned the Industrial Technology Research Institute to implement the "Smar...
PharmaEssentia Corporation, a global biopharmaceutical innovator headquartered in Taiwan leveraging deep expertise and p...
Taiwan Main Orthopaedic Biotechnology (Surglasses), a medtech startup based in Taiwan, has announced that Caduceus S AR ...
German firm BioNTech SE has announced plans to accelerate and broaden the clinical development of its can...
Taiwan's Lotus Pharmaceuticals has announced that its Board of Directors has approved the acquisition of the trademark, ...
